Development of Novel Therapeutics for Select Pathogens (R21/R33)

Archived

National Institutes of Health

Description

The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications to support basic to translational research focused on development of novel therapeutics against select antibiotic-resistant gram-negative bacteria or influenza.

Who can apply

  • State governments
  • County governments
  • City or township governments
  • Special district governments
  • Independent school districts
  • Public and State controlled institutions of higher education
  • Native American tribal governments (Federally recognized)
  • Public housing authorities / Indian housing authorities
  • Native American tribal organizations (other than Federally recognized)
  • Nonprofits with 501(c)(3) status (other than higher education)
  • Nonprofits without 501(c)(3) status (other than higher education)
  • Private institutions of higher education
  • For-profit organizations other than small businesses
  • Small businesses
  • Others

Contact

NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV

Key dates & funding
  • PostedJun 25, 2014
  • ClosesOct 20, 2014
  • Award ceiling$300,000
  • Program funding$3,100,000
  • CFDA93.855, 93.856
Categories

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro